Bruker Balance Sheet Health
Financial Health criteria checks 4/6
Bruker has a total shareholder equity of $1.5B and total debt of $1.4B, which brings its debt-to-equity ratio to 94.9%. Its total assets and total liabilities are $4.5B and $3.1B respectively. Bruker's EBIT is $437.4M making its interest coverage ratio 51.5. It has cash and short-term investments of $352.9M.
Key information
94.9%
Debt to equity ratio
US$1.38b
Debt
Interest coverage ratio | 51.5x |
Cash | US$352.90m |
Equity | US$1.45b |
Total liabilities | US$3.06b |
Total assets | US$4.51b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B2RK34's short term assets ($2.1B) exceed its short term liabilities ($1.2B).
Long Term Liabilities: B2RK34's short term assets ($2.1B) exceed its long term liabilities ($1.9B).
Debt to Equity History and Analysis
Debt Level: B2RK34's net debt to equity ratio (70.6%) is considered high.
Reducing Debt: B2RK34's debt to equity ratio has increased from 35.4% to 94.9% over the past 5 years.
Debt Coverage: B2RK34's debt is well covered by operating cash flow (20.7%).
Interest Coverage: B2RK34's interest payments on its debt are well covered by EBIT (51.5x coverage).